Does MRI help in the evaluation, diagnosis, and risk stratification of patients suspected of having hypertrophic cardiomyopathy?
MRI is a valuable imaging modality for diagnosing hypertrophic cardiomyopathy and stratifying the risk of sudden cardiac death.
MRI has proven to be an important tool for the evaluation of patients suspected of having HCM because it can readily diagnose those with phenotypic expression of the disorder and can potentially identify the subset of patients at risk of sudden cardiac death.
Hansen et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: